Cue Biopharma
77 hedge funds and large institutions have $31M invested in Cue Biopharma in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 27 reducing their positions, and 10 closing their positions.
Holders
77
Holders Change
-3
Holders Change %
-3.75%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
27
Closed
10
Calls
$292K
Puts
$88K
Net Calls
+$204K
Net Calls Change
-$460K
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$283K |
| 2 |
CC
2
Carlson Capital
Dallas,
Texas
|
$37.8K |
| 3 |
3
BlackRock
New York
|
$4.24M |
| 4 |
AC
4
Annandale Capital
Dallas,
Texas
|
$0 |
| 5 |
5
Jane Street
New York
|
$0 |
